Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.

Cancers (Basel) · 2024 · PMC10854643 · PMID 38339235

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

a possible trendp = 0.240not close (p > 0.1)

Meanwhile, PSA and mSEPT9 differences remained insignificant, indicating a possible trend ( p = 0.240 and 0.263, respectively).

also in 228 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.